QA: Melinta Therapeutics INC NEW in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001461993_2014_Melinta_Therapeutics_INC_NEW.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001461993, Melinta Therapeutics INC NEW

  xvar xval
0 AssetsCurrent 98,537,066
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 137,721
3 remainder_Assets 333,031
4 LiabilitiesCurrent 10,861,590
5 LiabilitiesNoncurrent 12,538,238
6 remainder_Liabilities 5,632,600
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,433,447
9 ResearchAndDevelopmentExpense 41,299,695
10 remainder_Expenses 0
11 remainder_Revenues 7,812,966
12 remainder_NetIncome -2,114,530
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 99,007,818
1 Liabilities 29,032,428
2 Expenses 50,733,142
3 Revenues 7,812,966
4 StockholdersEquity 69,975,390
5 NetIncome -45,034,706
6 ComprehensiveNetIncome -45,034,706
7 BaseVar 94,350,442
8 EconomicCapitalRatiobeforeLimitedLiability 1.68
9 EconomicCapitalRatio 2.80

Edgar->Model Mapping

Feature Distribution

Change over Time